BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24610813)

  • 1. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
    Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
    J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
    Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
    J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
    Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
    Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
    Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
    J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity.
    Li B; Lu D; Chen Y; Zhao M; Zuo L
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro.
    He F; Bai J; Wang J; Zhai J; Tong L; Zhu G
    J Cell Physiol; 2019 Aug; 234(10):17314-17325. PubMed ID: 30786022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
    Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T
    Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
    Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
    J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading.
    You L; Temiyasathit S; Lee P; Kim CH; Tummala P; Yao W; Kingery W; Malone AM; Kwon RY; Jacobs CR
    Bone; 2008 Jan; 42(1):172-9. PubMed ID: 17997378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
    Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
    PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TiAl
    Wang Z; Deng Z; Gan J; Zhou G; Shi T; Wang Z; Huang Z; Qian H; Bao N; Guo T; Chen J; Zhang J; Liu F; Dong L; Zhao J
    Acta Biomater; 2017 Jan; 48():489-498. PubMed ID: 27838463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
    Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
    J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
    Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis.
    Kim HJ; Kim HJ; Choi Y; Bae MK; Hwang DS; Shin SH; Lee JY
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL subcellular trafficking and regulatory mechanisms in osteocytes.
    Honma M; Ikebuchi Y; Kariya Y; Hayashi M; Hayashi N; Aoki S; Suzuki H
    J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin
    Ma J; Wang A; Zhang H; Liu B; Geng Y; Xu Y; Zuo G; Jia P
    Bone; 2022 Nov; 164():116511. PubMed ID: 35933095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways.
    Liao C; Cheng T; Wang S; Zhang C; Jin L; Yang Y
    Bone; 2017 Aug; 101():10-20. PubMed ID: 28414140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH1R translocation to primary cilia in mechanically-stimulated ostecytes prevents osteoclast formation via regulation of CXCL5 and IL-6 secretion.
    Tirado-Cabrera I; Martin-Guerrero E; Heredero-Jimenez S; Ardura JA; Gortázar AR
    J Cell Physiol; 2022 Oct; 237(10):3927-3943. PubMed ID: 35933642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.